γ-hydroxybutyrate (GHB), γ-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) reduce the volume of cerebral infarction in rodent transient middle cerebral artery occlusion

Annals of the New York Academy of Sciences

Volumn 1074, Issue , 2006, Pages 537-544

  Sadasivan, Shankar ^a   Maher, Timothy J ^a   Quang, Lawrence S ^b,c  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

1,4 butanediol (1,4 BD); Middle cerebral artery occlusion (MCAO); Stroke; Transient focal cerebral ischemia; butyrolactone (GBL); hydroxybutyric acid (GHB)

Indexed keywords

1,4 BUTANEDIOL; 4 AMINOBUTYRIC ACID; 4 HYDROXYBUTYRIC ACID; GAMMA BUTYROLACTONE; NEUROPROTECTIVE AGENT; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN INFARCTION SIZE; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NONHUMAN; RAT; REPERFUSION INJURY;

RODENTIA;

EID: 33749555307     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1369.054     Document Type: Conference Paper

References (37)

1. SHANNON, M. & L. QUANG. 2000. Gamma-hydroxybutyrate, gamma-butyrolactone, and 1,4-butanediol: a case report and review of the literature. Ped. Emerg. Care 16: 435-440.
2. FULLER, D.E., C.S. HORNFELDT, J.S. KELLOWAY, et al. 2004. The Xyrem risk management program. Drug Saf. 27: 293-306.
3. KLEINSCHMIDT, S., U. GRUNDMANN, U. JANNECK, et al. 1997. Total intravenous anesthesia using propofol, gamma-hydroxybutyrate or midazolam in combination with sufentanil for patients undergoing coronary artery bypass surgery. Eur. J. Anaesthesiol. 14: 590-599.
4. KLEINSCHMIDT, S., U. GRUNDMANN, T. KNOCKE, et al. 1998. Total intravenous anaesthesia with gamma-hydroxybutyrate (GHB) and sufentanil in patients undergoing coronary artery bypass graft surgery: a comparison in patients with unimpaired and impaired left ventricular function. Eur. J. Anaesthesiol. 15: 559-564.
5. KLEINSCHMIDT, S., C. SCHELLHASE & F. MERTZUFFT. 1999. Continuous sedation during spinal anaesthesia: gamma-hydroxybutyrate vs propofol. Eur. J. Anaesthesiol. 16: 23-30.
6. EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION. Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs (electronic source). http://www.emcdda.eu.int/?nnodeid=2821 (accessed April 2005).
7. GALLIMBERTI, L., M.R. SPELLA, C.A. SONCINI, et al. 2000. Gamma-hydroxybutric acid in the treatment of alcohol and heroine dependence. Alcohol 20: 257-262.
8. GALLIMBERTI, L., G. CANTON, N. GENTILE, et al. 1989. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome. Lancet 2: 787-789.
9. GALLIMBERI, L., M. FERRI, S.D. FERRARA, et al. 1992. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: a double blind study. Alcohol Clin. Exp. Res. 16: 673-676.
10. ADDOLORATO, G., M. CIBIN, E. CAPRISTA, et al. 1999. Maintaining abstinence from alcohol with gamma-hydroxybutyric acid. Lancet 351: 38.
11. ADDOLORATO, G., E. CASTELLI, G.F. STEFANINI, et al. 1996. An open multicentric study evaluating 4-hydroxybuytric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol. 31: 341-345.
12. YOSUNKAYA, A., H. BARISKANER, M.E. USTUN, et al. 2004. Effect of gamma-hydroxybutyric acid on lipid peroxidation and tissue lactate level in experimental head trauma. J. Trauma 56: 585-590.
13. YOSUNKAYA, A., M.E. USTUN, H. BARISKANER, et al. 2004. Effect of gamma-hydroxybutyric acid on tissue Na+,K- ATPase levels after experimental head trauma. Acta Anaesthesiol. Scand. 48: 631-636.
14. GUNEY, O., J. BENGI CELIK, M. ARAZI, et al. 2004. Effects of gamma-hydroxybutyrate on cerebrospinal fluid lactate and glucose levels after spinal cord trauma. J. Clin. Neurosci. 11: 517-520.
15. VERGONI, A.V., A. OTTANI, A.R. BOTTICELLI, et al. 2000. Neuroprotective effect of γ-hydroxybutyrate in transient global cerebral ischemia in the rat. Eur. J. Pharmacol. 397: 75-84.
16. OTTANI, A., S. SALTINI, M. BARTIROMO, et al. 2003. Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage. Brain Res. 986: 181-190.
17. YOSUNKAYA, A., M.E. USTUN, H. BARISKANER, et al. 2004. Effect of gamma-hydroxybutyric acid on tissue Na+,K- ATPase levels after experimental head trauma. Acta Anaesthesiol. Scand. 48: 631-636.
18. GUNEY, O., J. BENGI CELIK, M. ARAZI, et al. 2004. Effects of gamma-hydroxybutyrate on cerebrospinal fluid lactate and glucose levels after spinal cord trauma. J. Clin. Neurosci. 11: 517-520.
19. VERGONI, A.V., A. OTTANI, A.R. BOTTICELLI, et al. 2000. Neuroprotective effect of γ-hydroxybutyrate in transient global cerebral ischemia in the rat. Eur. J. Pharmacol. 397: 75-84.
20. OTTANI, A., S. SALTINI, M. BARTIROMO, et al. 2003. Effect of gamma-hydroxybutyrate in two rat models of focal cerebral damage. Brain Res. 986: 181-190.
21. OTTANI, A., A.V. VERGONI, S. SALTINI, et al. Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. Eur. J. Pharmacol. 485: 183-191.
22. ASPEY, B.S., F.L. TAYLOR, M. TERRULI, et al. 2000. Temporary middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke and reperfusion. Neuropathol. Appl. Neurobiol. 26: 232-242.
23. BOYD, A.J., I.A. SHERMAN, F.G. SAIBIL, et al. 1990. The protective effect of gamma-hydroxybutyrate in regional intestinal ischemia in the hamster. Gastroenterology 99: 860-862.
24. SHERMAN, I.A., F.G. SAIBIL & T.I. JANOSSY. 1994. Gamma- hydroxybutyrate mediated protection of liver function after long-term hypothermic storage. Transplantation 57: 8-11.
25. BOYD, A.J., I.A. SHERMAN & F.G. SAIBIL. 1992. The cardiovascular effects of gamma-hydroxybutyrate following hemorrhage. Circ. Shock 38: 115-121.
26. DOSMUGAMBETOVA, R.S. 1983. Prevention of stress-related disorders in the contractile function of non-ischemic areas of the heart during myocardial infarction using gamma-hydroxybutyric acid. Bull. Exp. Biol. Med. 96: 28-30.
27. WOLFSON, L.I., O. SAKURADA & L. SOKOLORFF. 1977. Effects of gamma-butyrolactone on local cerebral glucose utilization in the rat. J. Neurochem. 29: 777-783.
28. ESCURET, E., B. ROQUEFEUIL, P. FREREBEAN, et al. 1977. Effect of hyperventilation associated with administration of central nervous depressants in brain injuries. Acta. Neurol. Scand. 56: 154-155.
29. ESCURET, E., C. CHAPRON, C. GENIEZ-BOUSCAREL, et al. 1982. Cerebral metabolic depression induced by sodium gamma-hydroxybutyrate in the treatment of severe traumatic comas. Agressologie 23: 51-56.
30. ESCURET, E., B. ROQUEFEUIL, P. FREREBEAU, et al. 1981. Cerebral metabolic effect of gamma-hydroxybutyrate in neurosurgical patients on artificial respiration. Agressologie 22: 163-167.
31. MACMILLAN, V. 1978. The effects of gamma-hydroxybutyrate and gamma-butyrolactone upon the energy metabolism of the normoxic and hypoxic rat brain. Brain Res. 146: 177-187.
32. MACMILLAN, V. 1979. A comparison of γ-hydroxybutyrate and γ-butyrolactone on cerebral carbohydrate metabolism. Can. J. Physiol. Pharmacol. 57: 787-797.
33. BRALET, J., P. BELEY, A.M. BRALET, et al. 1979. Influence of various agents on the development of brain edema in the rat following microembolism: protective effect of gamma-butyrolactone. Stroke 10: 653-656.
34. ARTRU, A.A., P.A. STEEN & J.D. MICHENFELDER. 1980. γ-Hydroxybutyrate: cerebral metabolic, vascular, and protective effects. J. Neurochem. 35: 1114-1119.
35. LAVYNE, M.H., R.J. HARIRI, T. TANKOSIC, et al. 1983. Effect of low dose γ-butyrolactone therapy on forebrain neuronal ischemia in the unrestrained, awake rat. Neurosurgery 12: 430-434.
36. MACMILLAN, V. 1980. Effects of gamma-hydroxybutyrate and gamma-butyrolactone on cerebral energy metabolism during exposure and recovery from hypoxemia-oligemia. Stroke 11: 271-277.
37. LO, E.H., T. DALKARA & M.A. MOSKOWITZ. 2003. Mechanisms, challenges and opportunities in stroke. Natl. Rev. Neurosci. 4: 399-415.